Bi Asset Management Fondsmaeglerselskab A Astrazeneca PLC Transaction History

Bi Asset Management Fondsmaeglerselskab A

$6.11 Billion
Q2 2024

A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Astrazeneca PLC stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 453,264 shares of AZN stock, worth $32.4 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

453,264

Previous 413,384 9.65%

Holding current value

$32.4 Million

Previous $28 Million 26.22%

% of portfolio

0.58%

Previous 0.53%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $2.66 Million - $3.22 Million	39,880 Added 9.65%	453,264 $35.4 Million
Q1 2024 May 03, 2024	BUY	$61.03 - $69.57 $5.97 Million - $6.8 Million	97,780 Added 30.98%	413,384 $28 Million
Q4 2023 Feb 09, 2024	BUY	$61.89 - $69.28 $298,619 - $334,276	4,825 Added 1.55%	315,604 $21.3 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $1.39 Million - $1.54 Million	-21,430 Reduced 6.45%	310,779 $21 Million
Q2 2023 Aug 03, 2023	SELL	$69.91 - $75.81 $3.17 Million - $3.44 Million	-45,403 Reduced 12.02%	332,209 $23.8 Million
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $315,244 - $357,427	-4,992 Reduced 1.3%	377,612 $26.2 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $1.34 Million - $1.73 Million	-24,627 Reduced 6.05%	382,604 $25.9 Million
Q3 2022 Nov 07, 2022	BUY	$53.02 - $135.75 $3.3 Million - $8.45 Million	62,263 Added 18.05%	407,231 $22.3 Million
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $2 Million - $2.4 Million	-33,796 Reduced 8.92%	344,968 $22.8 Million
Q1 2022 May 11, 2022	SELL	$55.72 - $67.12 $5,627 - $6,779	-101 Reduced 0.03%	378,764 $25.1 Million
Q4 2021 Feb 02, 2022	BUY	$54.02 - $63.83 $1 Million - $1.18 Million	18,543 Added 5.15%	378,865 $22.1 Million
Q3 2021 Nov 09, 2021	SELL	$55.56 - $60.79 $500,928 - $548,082	-9,016 Reduced 2.44%	360,322 $21.6 Million
Q2 2021 Aug 06, 2021	SELL	$48.42 - $60.18 $1.43 Million - $1.77 Million	-29,477 Reduced 7.39%	369,338 $22.1 Million
Q1 2021 May 10, 2021	SELL	$47.16 - $54.44 $5.11 Million - $5.9 Million	-108,352 Reduced 21.36%	398,815 $19.8 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $24.6 Million - $29.4 Million	507,167 New	507,167 $25.4 Million

Others Institutions Holding AZN

# of Institutions

1,348

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $221B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.

Account

Bi Asset Management Fondsmaeglerselskab A Astrazeneca PLC Transaction History